I-Mab Biopharma
IMAB
#9469
Rank
A$91.66 M
Marketcap
$1.12
Share price
-6.87%
Change (1 day)
-58.84%
Change (1 year)

I-Mab Biopharma (IMAB) - P/B ratio

P/B ratio as of April 2025 : 0.2476

According to I-Mab Biopharma's latest financial reports the company has a price-to-book ratio of 15.0382.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

I-Mab Biopharma - P/B ratio (from 2024 to 2023)

P/B ratio by year

Year P/B ratio Change
2024-12-310.3292-92.81%
2023-12-314.58-19.4%
2022-12-315.68-83.17%
2021-12-3133.731.81%
2020-12-3125.6
2019-12-31N/A
2018-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
3.48 1,303.49%๐Ÿ‡บ๐Ÿ‡ธ USA
0.9118 268.21%๐Ÿ‡บ๐Ÿ‡ธ USA